Safety Evaluation of Intranasal Use of DSM 32444 Postbiotic in Humans

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

September 26, 2022

Primary Completion Date

November 22, 2022

Study Completion Date

April 20, 2023

Conditions
Rhino Sinusitis
Interventions
DRUG

0.9% NaCl isotonic saline solution

The placebo-control in the phase I study was a 0.9% NaCl isotonic saline solution. This nasal spray solution has no pharmacological effect, but is considered to have a cleansing effect on the nose, supporting the treatment of nasal symptoms in nasal pathology. The solution is prepared by extracting 5 mL from 0.9% NaCl intravenous infusion 500 mL PP bottle (B.Braun, Germany, product declaration No. VD-32732-19). The solution is bottled in the same fully-sealed nasal spray device containing Bacillus subtilis DSM 32444 postbiotic, used for Sperovid.

COMBINATION_PRODUCT

Bacillus subtilis DSM32444, inactivated

Postbiotic DSM32444 is manufactured by HURO BIOTECH Company as a drug-grade active pharmaceutical ingredient. The Class A medical device containing Postbiotic DSM32444 is called Sperovid, which is manufactured by Dong Duoc Viet under ISO 13485:2016 standards for medical device. Sperovid has registration number: 220000033/PCBA-LA

Trial Locations (1)

Unknown

Thai Binh University of Medicine and Pharmacy, Thái Bình

All Listed Sponsors
collaborator

Thai Binh University of Medicine and Pharmacy

OTHER

lead

Huro Biotech Joint Stock Company

INDUSTRY